| Name | Clesrovimab |
|---|
| Description | Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |